A study featuring investigators from the University at Buffalo Clinical and Translational Science Institute (CTSI), Roswell Park Comprehensive Cancer Center, and CTSA (Clinical and Translational ...

“The projects awarded pilot studies grants for 2026 address important clinical and translational science questions,” says CTSI Director Sanjay Sethi, MD, SUNY Distinguished Professor of medicine and ...

The STCC Unified PD1/PDL1 Evaluation of Response (SUPER) study is a collaborative research effort led by the Singapore Translational Cancer Consortium (STCC) aimed at identifying biomarkers that ...

CAMBRIDGE, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (MCRB) (Seres or the Company), a leading live biotherapeutics company, today announced new translational biomarker results ...

In KRAS mutant 2L mCRC, pelareorep delivers prolonged survival benefit with a median PFS and median OS approximately 2.5x the current standard of care Translational data from multiple studies confirm ...

Pilot study of CBX-12 pharmacodynamics in patients with advanced solid tumors. Background: The gut microbiome (GM) is thought to influence host immunity by modulating multiple immunologic pathways.

BIRMINGHAM, Ala. – Adverse life events are a known and predominant risk factor for postpartum depression in women after delivery of their baby. Furthermore, the postpartum depression in women who have ...

INSIGHT: A phase 3, randomized, open-label study of ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib with KIT exon 11 + 17/18 mutations ...